Normative modeling of brain morphology reveals neuroanatomical heterogeneity and biological subtypes in major depressive disorder

preprint OA: closed
Full text JSON View at publisher
Full text 1,996 characters · extracted from oa-doi-fallback · 4 sections · click to expand

Abstract

BACKGROUND Major Depressive Disorder (MDD) is characterized by high neurobiological heterogeneity, which hinders precise diagnosis and treatment. Traditional group-level neuroimaging analyses fail to capture individual differences, while normative modeling offer a promising approach to quantify individual deviations from healthy brain structure patterns, facilitating the identification of biological subtypes and offering a data-driven framework to dissect this heterogeneity.

Methods

Using 1,190 healthy controls, we constructed normative developmental trajectories of gray matter volume (GMV) across 246 Brainnetome-defined regions using Bayesian linear regression. Deviation maps were derived for 398 MDD patients. k-means clustering was employed to identify GMV-based biotypes. Then, the clinical characteristics and anatomical differences among these subtypes were explored, along with the post-treatment clinical features and treatment responses of participants who completed the 8-week antidepressant treatment within each subtype.

Results

Patients with MDD exhibited widespread yet individually variable GMV deviations. Clustering analysis revealed two subtypes: Subtype 1 displayed predominantly negative deviations in sensorimotor and occipital cortices, whereas Subtype 2 showed widespread positive deviations in temporal and posterior cingulate regions. Subtype 1 had higher extraversion and symptom-linked deviation patterns; in Subtype 2, deviation burden correlated with generalized anxiety. Longitudinally, Subtype 1’s GMV deviation changes predicted symptom improvement, while Subtype 2’s deviations correlated with baseline severity.

Conclusions

Normative modeling of GMV reveals marked neuroanatomical heterogeneity in MDD and identifies subtypes with distinct clinical and treatment-related characteristics, laying a foundation for precision psychiatry and individualized interventions. Competing Interest Statement The authors have declared no competing interest.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00